logo
Plus   Neg
Share
Email

EARNINGS SUMMARY: Details of CTI BioPharma Corp. Q3 Earnings Report

Below are the earnings highlights for CTI BioPharma Corp. (CTIC):

-Earnings: -$10.05 million in Q3 vs. -$14.81 million in the same period last year.
-EPS: -$0.17 in Q3 vs. -$0.26 in the same period last year.
-Analysts projected -$0.23 per share
-Revenue: $2.29 million in Q3 vs. $0.72 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT